• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[巴西联邦区乳腺癌治疗的可及间隔时间]

[Interval for access to treatment for breast cancer in the Federal District, Brazil].

作者信息

Barros Ângela Ferreira, Uemura Gilberto, de Macedo Jefferson Lessa Soares

出版信息

Rev Bras Ginecol Obstet. 2013 Oct;35(10):458-63. doi: 10.1590/s0100-72032013001000006.

DOI:10.1590/s0100-72032013001000006
PMID:24337058
Abstract

PURPOSE

To analyze the time between the first symptom and treatment in patients treated for breast cancer in public hospitals in the Federal District.

METHODS

This was a cross-sectional analysis. We interviewed 250 women diagnosed with breast cancer treated in six hospitals of the State Department of Health of the Federal District from November 2009 to January 2011. The time intervals studied were the time between the detection of the symptoms and treatment subdivided into intervals until and after the first medical appointment. The variables were: age, menopausal status, color, educational level, average monthly household income, origin, reason for the initial consultation, staging, tumor size, laterality, metastasis to axillary lymph nodes, neoadjuvant chemotherapy, and type of surgery. The Mann-Whtney test was used to assess the association of these variables with the time intervals until treatment.

RESULTS

The mean age was 52 years, with a predominance of white women (57.6%), from the Federal District (62.4%), with a family income of up to 2 minimum wages (78%), and up to four years of schooling (52.4%). The staging of the disease ranged from II to IV in 78.8% of the women. The time between the first symptom and treatment was 229 days (median). After detection of the first symptom, 52.9% of the women attended a consultation within 30 days and 88.8% took more than 90 days to start treatment. Women with elementary school education had a greater delay to the start of treatment (p=0.049).

CONCLUSIONS

There was a significant delay to start treatment of women with breast cancer in public hospitals of the Federal District, suggesting that efforts should be made to reduce the time needed to schedule medical appointments and to diagnose and treat these patients.

摘要

目的

分析在联邦区公立医院接受乳腺癌治疗的患者从出现首个症状到接受治疗之间的时间。

方法

这是一项横断面分析。我们对2009年11月至2011年1月期间在联邦区卫生部的六家医院接受乳腺癌诊断的250名女性进行了访谈。所研究的时间间隔是从症状出现到治疗之间的时间,细分为首次就诊之前和之后的时间段。变量包括:年龄、绝经状态、肤色、教育水平、家庭月平均收入、籍贯、初诊原因、分期、肿瘤大小、患侧、腋窝淋巴结转移、新辅助化疗以及手术类型。采用曼-惠特尼检验来评估这些变量与治疗前时间间隔之间的关联。

结果

平均年龄为52岁,以白人女性为主(57.6%),来自联邦区(62.4%),家庭收入至多为2份最低工资(78%),且受教育年限至多为四年(52.4%)。78.8%的女性疾病分期为II至IV期。从首个症状出现到接受治疗的时间为中位数229天。在出现首个症状后,52.9%的女性在30天内就诊,88.8%的女性超过90天才开始治疗。小学文化程度的女性开始治疗的延迟时间更长(p = 0.

相似文献

1
[Interval for access to treatment for breast cancer in the Federal District, Brazil].[巴西联邦区乳腺癌治疗的可及间隔时间]
Rev Bras Ginecol Obstet. 2013 Oct;35(10):458-63. doi: 10.1590/s0100-72032013001000006.
2
Clinical pathways of breast cancer patients treated in the Federal District, Brazil.巴西联邦区乳腺癌患者的临床路径。
Rev Saude Publica. 2019 Jan 31;53:14. doi: 10.11606/S1518-8787.2019053000406.
3
Factors associated with time interval between the onset of symptoms and first medical visit in women with breast cancer.与乳腺癌女性症状发作与首次就诊时间间隔相关的因素。
Cad Saude Publica. 2020 Jan 31;36(2):e00011919. doi: 10.1590/0102-311X00011919. eCollection 2020.
4
Treatment delays among women with breast cancer in a low socio-economic status region in Brazil.巴西一个社会经济地位较低地区乳腺癌女性患者的治疗延误情况。
BMC Womens Health. 2017 Feb 21;17(1):13. doi: 10.1186/s12905-016-0359-6.
5
Inequality in breast cancer care in a Brazilian capital city: a comparative analysis of narratives.巴西首都的乳腺癌护理不平等:叙事的比较分析。
Int J Equity Health. 2019 Jun 13;18(1):88. doi: 10.1186/s12939-019-0989-z.
6
Factors influencing delay in symptomatic presentation of breast cancer in Brazilian women.影响巴西女性乳腺癌症状表现延迟的因素。
Health Soc Care Community. 2019 Nov;27(6):1525-1533. doi: 10.1111/hsc.12823. Epub 2019 Aug 5.
7
[Factors leading to delay in obtaining definitive diagnosis of suspicious lesions for breast cancer in a dedicated health unit in Rio de Janeiro].[导致里约热内卢一家专门医疗机构中乳腺癌可疑病变确诊延迟的因素]
Rev Bras Ginecol Obstet. 2009 Feb;31(2):75-81. doi: 10.1590/s0100-72032009000200005.
8
Delayed presentation of symptomatic breast cancers in Hong Kong: experience in a public cancer centre.香港有症状乳腺癌的延迟就诊:一家公立癌症中心的经验。
Hong Kong Med J. 2010 Oct;16(5):373-7.
9
Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires.布宜诺斯艾利斯市公立和私立医院的乳腺癌和肺癌患者接受化疗治疗的情况。
Int J Qual Health Care. 2019 Nov 30;31(9):682-690. doi: 10.1093/intqhc/mzz047.
10
Social vulnerability and breast cancer: differentials in the interval between diagnosis and treatment of women with different sociodemographic profiles.社会脆弱性与乳腺癌:不同社会人口学特征女性在诊断与治疗间隔上的差异
Cien Saude Colet. 2019 Feb;24(2):613-622. doi: 10.1590/1413-81232018242.31672016.

引用本文的文献

1
Patient journey and timeliness of care for patients with breast cancer in Africa: a scoping review.非洲乳腺癌患者的就医历程与医疗及时性:一项范围综述
BMJ Open. 2025 Aug 31;15(8):e098087. doi: 10.1136/bmjopen-2024-098087.
2
Delayed breast cancer presentation, diagnosis, and treatment in Kenya.肯尼亚乳腺癌的延迟就诊、诊断和治疗。
Breast Cancer Res Treat. 2023 Dec;202(3):515-527. doi: 10.1007/s10549-023-07067-y. Epub 2023 Sep 5.
3
Shorter delay to treatment by integrated diagnostic services and NGO-provided support among breast cancer patients in two Brazilian referral centres.
在巴西的两个转诊中心,综合诊断服务和非政府组织提供的支持使乳腺癌患者的治疗延迟时间缩短。
J Public Health Res. 2021 Mar 10;10(3):1880. doi: 10.4081/jphr.2021.1880.
4
Analysis of the Immunoexpression of Opioid Receptors and their Correlation with Markers of Angiogenesis, Cell Proliferation and Apoptosis in Breast Cancer.乳腺癌中阿片受体的免疫表达分析及其与血管生成、细胞增殖和凋亡标志物的相关性
Asian Pac J Cancer Prev. 2021 Feb 1;22(2):633-640. doi: 10.31557/APJCP.2021.22.2.633.
5
Availability of Diagnostic Services and their Impact on Patient Flow in Two Brazilian Referral Centres of Breast Cancer Treatment.巴西两个乳腺癌治疗转诊中心的诊断服务可及性及其对患者流量的影响。
Asian Pac J Cancer Prev. 2020 Feb 1;21(2):317-324. doi: 10.31557/APJCP.2020.21.2.317.
6
Realizing the right to health in Brazil's Unified Health System through the lens of breast and cervical cancer.通过乳腺癌和宫颈癌视角看巴西统一卫生系统中健康权的实现。
Int J Equity Health. 2019 Jun 3;18(1):39. doi: 10.1186/s12939-019-0938-x.
7
Locally advanced breast cancer in young women in Latin America.拉丁美洲年轻女性的局部晚期乳腺癌
Ecancermedicalscience. 2019 Jan 22;13:894. doi: 10.3332/ecancer.2019.894. eCollection 2019.
8
Clinical pathways of breast cancer patients treated in the Federal District, Brazil.巴西联邦区乳腺癌患者的临床路径。
Rev Saude Publica. 2019 Jan 31;53:14. doi: 10.11606/S1518-8787.2019053000406.
9
Evaluation of waiting times for breast cancer diagnosis and surgical treatment.乳腺癌诊断和手术治疗等待时间的评估。
Clin Transl Oncol. 2018 Oct;20(10):1345-1352. doi: 10.1007/s12094-018-1867-7. Epub 2018 Apr 9.
10
Delayed presentation and diagnosis of breast cancer in African women: a systematic review.非洲女性乳腺癌的延迟就诊与诊断:一项系统评价
Ann Epidemiol. 2017 Oct;27(10):659-671.e7. doi: 10.1016/j.annepidem.2017.09.007. Epub 2017 Sep 22.